Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia (SALSA II Trial)

NCT04949139 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04949139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04949139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia (SALSA II Trial)
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2021
Completion date
February 22, 2025
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypernatremia